These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33992040)

  • 1. Can treating critically-ill haematological malignancy patients in a separate intensive care unit decrease intensive care unit mortality?
    Aygencel G; Boyacı Dündar N; Türkoğlu M; Yegin ZA; Özkurt ZN; Yağcı AM
    Turk J Med Sci; 2021 Aug; 51(4):2095-2100. PubMed ID: 33992040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for ICU mortality in patients with hematological malignancies: a singlecenter, retrospective cohort study from Turkey.
    Bıkmaz ŞGA; Gökçe O; Haşimoğlu MM; Boyacı N; Türkoğlu M; Yeğin ZA; Özkurt ZN; Yağcı AM
    Turk J Med Sci; 2023 Feb; 53(1):340-351. PubMed ID: 36945922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5 yr study.
    Bird GT; Farquhar-Smith P; Wigmore T; Potter M; Gruber PC
    Br J Anaesth; 2012 Mar; 108(3):452-9. PubMed ID: 22298243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies.
    Benoit DD; Hoste EA; Depuydt PO; Offner FC; Lameire NH; Vandewoude KH; Dhondt AW; Noens LA; Decruyenaere JM
    Nephrol Dial Transplant; 2005 Mar; 20(3):552-8. PubMed ID: 15671075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and outcomes of haematology patients admitted to the intensive care unit.
    McCaughey C; Blackwood B; Glackin M; Brady M; McMullin MF
    Nurs Crit Care; 2013 Jul; 18(4):193-9. PubMed ID: 23782113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of Poor Outcomes in Critically Ill Adults with Hematologic Malignancy.
    Cornish M; Butler MB; Green RS
    Can Respir J; 2016; 2016():9431385. PubMed ID: 27445571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in critically ill patients with hematologic malignancies admitted to the intensive care unit.
    Yeo CD; Kim JW; Kim SC; Kim YK; Kim KH; Kim HJ; Lee S; Rhee CK
    J Crit Care; 2012 Dec; 27(6):739.e1-6. PubMed ID: 23217573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis of hematologic malignancies does not predict intensive care unit mortality.
    Massion PB; Dive AM; Doyen C; Bulpa P; Jamart J; Bosly A; Installé E
    Crit Care Med; 2002 Oct; 30(10):2260-70. PubMed ID: 12394954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid response system for critically ill patients with haematological malignancies: A pre- and post-intervention study.
    Mauz N; Bouisse M; Cahn JY; Kaphan E; Truche AS; Thiebaut-Bertrand A; Carré M; Bulabois CE; Hamidfar-Roy R; Schwebel C; Park S; Labarere J; Terzi N
    Eur J Haematol; 2024 Sep; 113(3):330-339. PubMed ID: 38780264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematologic malignancies in the medical intensive care unit--Outcomes and prognostic factors.
    Grgić Medić M; Gornik I; Gašparović V
    Hematology; 2015 Jun; 20(5):247-53. PubMed ID: 25310461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in critically ill cancer patients admitted to the intensive care unit.
    Aygencel G; Turkoglu M; Turkoz Sucak G; Benekli M
    J Crit Care; 2014 Aug; 29(4):618-26. PubMed ID: 24612762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of outcome in patients with hematologic malignancies admitted to the intensive care unit.
    Al-Zubaidi N; Shehada E; Alshabani K; ZazaDitYafawi J; Kingah P; Soubani AO
    Hematol Oncol Stem Cell Ther; 2018 Dec; 11(4):206-218. PubMed ID: 29684341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematological malignancies in Polish population: what are the predictors of outcome in patients admitted to Intensive Care Unit?
    Kalicińska E; Kuszczak B; Dębski J; Szukalski Ł; Wątek M; Strzała J; Rybka J; Czyż J; Lech-Marańda E; Zaucha J; Wróbel T
    Support Care Cancer; 2021 Jan; 29(1):323-330. PubMed ID: 32361829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of 6-month survival of critically ill patients with an active hematologic malignancy.
    Richards S; Wibrow B; Anstey M; Sidiqi H; Chee A; Ho KM
    J Crit Care; 2016 Dec; 36():252-258. PubMed ID: 27637467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in critically ill patients with hematological malignancy admitted to the general intensive care unit: a single-center experience in Japan.
    Irie H; Otake T; Kawai K; Hino M; Namazu A; Shinjo Y; Yamashita S
    J Anesth; 2017 Oct; 31(5):736-743. PubMed ID: 28766020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of haematology/oncology patients admitted to intensive care unit at The Canberra Hospital.
    Parakh S; Piggin A; Neeman T; Mitchell I; Crispin P; Davis A
    Intern Med J; 2014 Nov; 44(11):1087-94. PubMed ID: 25132619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Admission factors associated with hospital mortality in patients with haematological malignancy admitted to UK adult, general critical care units: a secondary analysis of the ICNARC Case Mix Programme Database.
    Hampshire PA; Welch CA; McCrossan LA; Francis K; Harrison DA
    Crit Care; 2009; 13(4):R137. PubMed ID: 19706163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis-related factors in intensive care unit (ICU) patients with hematological malignancies: A retrospective cohort analysis in a Chinese population.
    Liu J; Cheng Q; Yang Q; Li X; Shen X; Zhang L; Liu Z; Khoshnood K
    Hematology; 2015 Oct; 20(9):494-503. PubMed ID: 25585045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NRS-2002 and mNUTRIC score: Could we predict mortality of hematological malignancy patients in the ICU?
    İleri İ; Özsürekci C; Halil MG; Gündoğan K
    Nutr Clin Pract; 2022 Oct; 37(5):1199-1205. PubMed ID: 34587327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of patients with hematological malignancy admitted to the intensive care unit: prognostic factors and outcome compared to unselected medical intensive care unit admissions, a parallel group study.
    Hill QA; Kelly RJ; Patalappa C; Whittle AM; Scally AJ; Hughes A; Ashcroft AJ; Hill A
    Leuk Lymphoma; 2012 Feb; 53(2):282-8. PubMed ID: 21846185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.